Oxford Immunotec
Oxford Immunotec Nabs CE Mark for COVID-19 T-Cell Response Test
The firm said its T-cell test complements serology testing and provides a more comprehensive view of the adaptive immune response to SARS-CoV-2 infection.
Oxford Immunotec, Valneva Collaborate on COVID-19 Vaccine Study
Oxford Immunotec's T-Spot Discovery SARC-CoV-2 test will be used to assess whether Valneva's vaccine candidate induces a T-cell response.
PerkinElmer to Buy Oxford Immunotec for $591M
The deal will enable PerkinElmer to grow its infectious disease testing portfolio to include latent tuberculosis detection, it said.